New eye injection shows promise for Diabetes-Related vision loss
NCT ID NCT05959304
First seen Jan 04, 2026 · Last updated May 10, 2026 · Updated 27 times
Summary
This study tested the safety and effectiveness of brolucizumab eye injections in 66 adults with diabetic macular edema, a condition that causes vision loss in people with diabetes. Participants received injections over 40 weeks to see if their vision improved and to track any side effects. The goal was to gather real-world data in Indian patients to support ongoing use of this treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Ahmedabad, Gujarat, 380052, India
-
Novartis Investigative Site
Bangalore, Karnataka, 560 010, India
-
Novartis Investigative Site
Kochi, Kerala, 682 026, India
-
Novartis Investigative Site
Chennai, Tamil Nadu, 600045, India
-
Novartis Investigative Site
Kolkata, West Bengal, 700 073, India
-
Novartis Investigative Site
Coimbatore, 641002, India
-
Novartis Investigative Site
Kolkata, 700120, India
-
Novartis Investigative Site
New Delhi, 110029, India
Conditions
Explore the condition pages connected to this study.